Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Non Insulin Dependent Diabetes Mellitus
50%
sodium glucose cotransporter-2 inhibitors
50%
Psoriasis
33%
Biological Product
33%
Hydrochlorothiazide
33%
Skin Cancer
22%
Glucagon Like Peptide 1 Receptor Agonist
18%
Photodynamic Therapy
16%
Thiazide Diuretic Agent
16%
Immune Checkpoint Inhibitor
16%
Dry Eye
16%
Receptor Agonist
16%
Oxidoreductase
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Glaucoma
16%
Secukinumab
16%
Eye Disease
16%
Tumor Necrosis Factor
16%
Diabetic Macular Edema
16%
Age Related Macular Degeneration
16%
Hepatitis C Virus
16%
Hepatitis B Virus
16%
Epidermolysis
16%
Betaxolol
16%
Antihypertensive
14%
Ustekinumab
13%
Adalimumab
13%
Non Melanoma Skin Cancer
13%
Tamsulosin
9%
Diuretics
8%
Prostate Hypertrophy
7%
HLA B13 Antigen
7%
Lip Cancer
6%
Basal Cell Carcinoma
6%
Squamous Cell Carcinoma
6%
Stevens Johnson Syndrome
6%
Toxic Epidermal Necrolysis
6%
Dutasteride
5%
Finasteride
5%
Keyphrases
Hepatitis C Virus Reactivation
16%
Population-based Cohort Study
16%
SPADE
16%
Emulation Framework
16%
Pathognomonic
16%
Intralesional Cryosurgery
16%
Extragenital
16%
Daylight Photodynamic Therapy
16%
Target Trial Emulation
16%
Cataract Surgery
16%
TNF Blockade
16%
Epidermal Necrolysis
16%
Taiwan
16%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
Cutaneous Cytomegalovirus
16%
Secukinumab
16%
Single Irradiation
16%
Scleritis
16%
Epibulbar Tumor
16%
Anterior Uveitis
16%
Diabetic Macular Edema
16%
Perianal Paget's Disease
16%
Photodermatoses
16%
Hydrochlorothiazide
16%
Glucagon-like peptide-1 (GLP-1)
16%
Retinal Vascular Occlusion
16%
Multi-institutional
16%
Betaxolol
16%
Type 2 Diabetic Patients
16%
Unilateral Blindness
16%
Ophthalmic Artery Occlusion
16%
Cutaneous Lymphoma
16%
Geographic Ulcer
16%
Non-melanoma Skin Cancer
13%
5ARI
12%
Confidence Interval
12%
Hazard Ratio
12%
Corneal Ulcer
11%
Receptor Agonist
8%
A1 Receptor
8%
Glucagon-like
8%
Dissecting Cellulitis
7%
Central Centrifugal Cicatricial Alopecia
7%
Facial Nodule
6%
Anorectal Carcinoma
6%
Central Macular Thickness
6%
Fundoscopic Examination
6%
Viral Polymerase
5%
Fluorescein Staining
5%
Epithelial Keratitis
5%
Medicine and Dentistry
Cohort Analysis
33%
Photochemotherapy
16%
Giant Condyloma Acuminatum
16%
Rosai-Dorfman Disease
16%
Iridocyclitis
16%
Meta-Analysis
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Cataract Surgery
16%
Phacoemulsification
16%
Scalp
16%
Lung Cancer
16%
Fibrosis
16%
Acneiform Eruption
16%
Dermis
16%
Hydrochlorothiazide
16%
Maturity Onset Diabetes of the Young
16%
Pathognomonic
16%
Scleritis
16%
Neoplasm
16%
Cytomegalovirus Infection
16%
Systematic Review
16%
Psoriasis
16%
Diabetic Macular Edema
16%
Immunogenetics
16%
Ophthalmic Artery
16%
Biological Product
16%
Cutaneous Lymphoma
16%
Non Melanoma Skin Cancer
13%
Hazard Ratio
13%
Erlotinib
11%
Cytomegalovirus
11%
Chlorphenamidine
11%
Cicatricial Alopecia
9%
Glucagon-Like Peptide-1 Agonist
8%
Biopsy Technique
7%
HLA B13 Antigen
7%
Podophyllotoxin
6%
Recurrent Disease
6%
Lip Cancer
6%
Corneal Ulcer
6%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Pseudopelade of Brocq
5%
Enzyme Linked Immunosorbent Assay
5%
Infection
5%
Acne Keloidalis Nuchae
5%
Virus Infection
5%
Ulcer
5%
Brain Metastasis
5%
Disseminated Disease
5%
Endothelial Cell
5%
